System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Fabrice Lecuru is an expert in Gynecology at Institut Curie (France). As of October 2026, ScienceLeadR ranks Fabrice Lecuru in the top 1% of experts worldwide for Uterine Diseases, Ovarian Neoplasms and Adnexal Diseases. Fabrice Lecuru has authored 483 publications, the most recent in 2026, and is an investigator in 11 clinical trials, 1 of them ongoing. SLR score: 1,583 (community average: 125). How the SLR is computed.

LeadR Profile

Fabrice Lecuru Institut Curie France
1 583 ScienceLeadR Reputation 1583

Unlock

Register Login
Network Map

Gynecology

Subspecialties: Oncology - Surgery

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1993 - 2026
Source: PubMed

Assistance Publique - Hôpitaux de Paris

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 483

Citations

Citations: 10 071 1st author: 70 Last author: 166 Unique author: 5

Main journals

Gynecol Oncol 44
Int J Gynecol Cancer 38
Bull Cancer 29
J Gynecol Obstet Biol Reprod (Paris) 23
J Clin Oncol 21

Best Journals

Ann Oncol 5
J Clin Oncol 5
Lancet Oncol 3

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Consensus statements from the first Gynecologic Cancer InterGroup Cervical Cancer Consensus Conference in Clinical Research.
PMID 42508438 — biomedical research, uterine cervical neoplasms, genital neoplasms, female, neoplasms, income, research		Lancet Oncol Top journal20262
Efficacy of secondary cytoreductive surgery for relapsed ovarian low-grade serous carcinoma: a multicenter analysis from French TMRG network.
PMID 42411723 — cytoreduction surgical procedures, ovary, neoplasms, ovarian neoplasms		J Gynecol Oncol20260
Prognostic impact of time to first recurrence in low-grade serous ovarian carcinoma: A multicentric retrospective study from the French TMRG network.
PMID 42361574 — cytoreduction surgical procedures, ovary, genital neoplasms, female, retrospective studies, ovarian neoplasms		Gynecol Oncol20260
ESGO Consensus Statement on endometrial cancer prevention, risk reduction strategies, and management of women with Lynch syndrome.
PMID 42090914 — neoplasms, endometrial neoplasms		Eur J Cancer20260
Surgical modality non-inferiority testing with an intensification of adjuvant treatments: a missed opportunity.
PMID 41985224 — research design, therapeutics		Int J Gynecol Cancer20260

Clinical Studies 11

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

N/A 8
Phase 3 3

By status:

Completed 6
Active not recruiting 3
Recruiting 1
Unknown 1

By type:

Interventional 10
Observational 1

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 0
multicentric5to9 0
multicentricup10 8

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
PARa aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer
NCT05581121 — radiotherapy, carcinoma, adenosquamous, lymph nodes, lymph node excision, uterine cervical neoplasms, brachytherapy, neoplasms, adenocarcinoma, laparoscopy, human papillomavirus 16, lymph, therapeutics, carcinoma		Phase 3Recruiting2023

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS